Acadia Pharmaceuticals Inc - Company & Market Research Reports

Acadia Pharmaceuticals is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. Its lead product candidate, NUPLAZID, has completed the Phase III pivotal trials for the treatment of Parkinson's disease, Phase II trial for the treatment of schizophrenia and Phase II study for the treatment of Alzheimer's disease. The company was founded in 1993 and is headquartered in San Diego, California.


Attention Deficit Hyperactivity Disorder (ADHD): Market Intelligence Review and Insights - Product Thumbnail Image

Attention Deficit Hyperactivity Disorder (ADHD): Market Intelligence Review and Insights

  • Report
  • 50 Pages
From
Neuropathic Pain - Pipeline Review, H2 2017 - Product Thumbnail Image

Neuropathic Pain - Pipeline Review, H2 2017

  • Report
  • 488 Pages
From
Neuropathic Pain - Pipeline Review, H1 2017 - Product Thumbnail Image

Neuropathic Pain - Pipeline Review, H1 2017

  • Report
  • 485 Pages
From
Lewy body Dementia Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Lewy body Dementia Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 57 Pages
From
Estrogen Receptor Beta Partial Agonist -Pipeline Insight, 2018 - Product Thumbnail Image

Estrogen Receptor Beta Partial Agonist -Pipeline Insight, 2018

  • Drug Pipelines
  • 60 Pages
From
Pain Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Pain Drug Development Pipeline Review, 2017

  • Report
  • 229 Pages
From
Parkinson's: Disease Inights and Market Forecasts to 2024 - Product Thumbnail Image

Parkinson's: Disease Inights and Market Forecasts to 2024

  • Report
  • 120 Pages
From
Parkinson's: Market Intelligence Review and Insights - Product Thumbnail Image

Parkinson's: Market Intelligence Review and Insights

  • Report
  • 50 Pages
From
Parkinson's: Pipeline Assessment and Insights - Product Thumbnail Image

Parkinson's: Pipeline Assessment and Insights

  • Report
  • 100 Pages
From
Parkinson's: Epidemiology Overview and Insights - Product Thumbnail Image

Parkinson's: Epidemiology Overview and Insights

  • Report
  • 50 Pages
From
Global Parkinson's Disease Drugs Market Outlook 2022 - Product Thumbnail Image

Global Parkinson's Disease Drugs Market Outlook 2022

  • Report
  • 100 Pages
From
Parkinson's Disease Therapeutics in Major Developed Markets to 2021: Early Pipeline Shifts Towards Disease-Modifying Therapies, while Short Term Growth Driven by Long-Acting Symptomatic Treatments - Product Thumbnail Image

Parkinson's Disease Therapeutics in Major Developed Markets to 2021: Early Pipeline Shifts Towards Disease-Modifying Therapies, while Short Term Growth Driven by Long-Acting Symptomatic Treatments

  • Report
  • 136 Pages
From
Parkinson's Disease - Market Insights, Epidemiology and Market Forecast 2017 - 2025 - Product Thumbnail Image

Parkinson's Disease - Market Insights, Epidemiology and Market Forecast 2017 - 2025

  • Drug Pipelines
  • 69 Pages
From
Dementia - Pipeline Review, H1 2018 - Product Thumbnail Image

Dementia - Pipeline Review, H1 2018

  • Report
  • 260 Pages
From
Huntington's Disease - Pipeline Review, H1 2015 - Product Thumbnail Image

Huntington's Disease - Pipeline Review, H1 2015

  • Report
  • 305 Pages
From
The 2018-2023 World Outlook for Parkinson's Disease Treatments - Product Thumbnail Image

The 2018-2023 World Outlook for Parkinson's Disease Treatments

  • Report
  • 292 Pages
Alzheimer's: Disease Inights and Market Forecasts to 2024 - Product Thumbnail Image

Alzheimer's: Disease Inights and Market Forecasts to 2024

  • Report
  • 120 Pages
From
Alzheimer s: Epidemiology Overview and Insights - Product Thumbnail Image

Alzheimer s: Epidemiology Overview and Insights

  • Report
  • 50 Pages
From
Global Alzheimer's Therapeutics Market Analysis 2016 - Forecast to 2022 - Product Thumbnail Image

Global Alzheimer's Therapeutics Market Analysis 2016 - Forecast to 2022

  • Report
  • 138 Pages
From
Global Alzheimer's Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2015 to 2022 - Product Thumbnail Image

Global Alzheimer's Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2015 to 2022

  • Report
From
Loading Indicator
adroll